The USFDA recently approved a label amendment of Smith and Nephew's Advanced Wound Management Division's advanced surgical wound management product, VERSAJET™.

VERSAJET™ has been granted burn indication clearance from the FDA, in addition to its approval for the surgical debridement (removal of dead tissue) of a wide variety of other wounds, including chronic and acute wounds.

The VERSAJET Hydrosurgery System is a specialized waterjet-powered surgical device designed to establish a new standard of patient care and procedural efficiency in surgical wound management.

Accelerating a hair thin stream of fluid to supersonic speeds, the system enables surgeons to simultaneously grasp, cut and remove damaged tissue and contaminants precisely, without collateral tissue damage associated with current surgical treatment methods.

VERSAJET is used in many surgical specialties for the debridement of wounds, including in orthopedic, vascular, podiatric, plastic and general surgery.Smith and Nephew.